Navigation Links
Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31, 2008
Date:7/24/2008

STEWARTVILLE, Minn., July 24 /PRNewswire-FirstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM) will announce quarterly results after financial markets close on Thursday, July 31 2008. The Company will then hold a quarterly conference call to discuss its earnings report. The call will begin at 4:00 p.m. central daylight time (5:00 p.m. eastern time).

This call is being webcast by Thomson/CCBN and can be accessed at Rochester Medical's website at http://www.rocm.com. To listen live to the conference call via telephone, call:

Domestic: 888.680.0860, password 56839487

International: 617.213.4852, password 56839487

Pre Registration:

https://www.theconferencingservice.com/prereg/key.process?key=PJ47TFMGM

Replay will be available for seven days at http://www.rocm.com or via telephone at:

Domestic: 888-286-8010, password 66511681

International: 617-801-6888, password 66511681

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com).

Rochester Medical Corporation develops, manufactures, and m
'/>"/>

SOURCE Rochester Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rochester Medical Announces Second Quarter 2008 Earnings Conference Call April 29, 2008
2. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
3. Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop Designer Transplants
4. Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
5. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
6. Saving Certified Continuing Medical Education (CME)
7. ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
8. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
9. RADI Medical Systems Launches Next Generation PressureWire(R) Certus
10. BioElectronics ActiPatch(TM) Product Chosen as One of 9 Medical Breakthroughs That May Change Your Life
11. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...a, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceuti...R ), a leading pharmaceutical company,specializing...of branded,generic and proprietary pharmaceuticals...ave been included in China,s National Drug Reimbur...Ministry of Human Resources and Social,Security on...
(Date:12/2/2009)...ientist, a leading scientific magazine covering th... “Intelligent” EMCCD camera fourth amo...ns of 2009. , (PRWEB) Dec...from Photometrics ®, a designer and manufact... the life sciences, was ranked fourth among The Sc...
(Date:12/1/2009)..., Dec. 1 PDL BioPharma, ...e guidance for the fourth quarter ended December 3...with $69 million for the fourth quarter of 2008. I...st of two installment payments of $12.5 million fr...results was a one-time $1.8 million payment from G...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Emerging Clinical Trial Location...ng healthcare and regulatory environment ,, h...cal-Trial-Locations---Eastern-Europe-Market-dynami...ronment.html ,, Over the last decade pharmaceu...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...g radio frequency identification (RFID) software f...en is the world,s largest manufacturer of cordless...Best Buy prompted Uniden to engage the supply chai...e telephone maker is using CatalystCommand iRFID t...y chain environment. , ,Uniden America Corp. is t...
...ll begins its 2005 season, researchers at the Uni... to demonstrate their school spirit. The only fans... high-powered microscopes. , ,Last month a team of...rs created "NanoBucky", an image of the universit...nometers long. With each nanofiber a thousandth th...
...tunity to define public discourse over nanotechnol...le information about the emerging technology, a Un... says. , ,"The message to scientists is: The publi...ur work to the public, and make it available where...ed one of the first national surveys on public kno...
Other Biology Technology:Nanotechnology minimizes UW's beloved mascot 2UW study examines public attitudes on nanotechnology 2
(Date:12/2/2009)... student at the University of Southampton,s School... Oceanography Centre, Southampton (NOCS) has forma...rom the deep sea. , Hall discovered the new spec... Museum of Natural History in Washington. Explaini...rabs include some of the largest crustaceans curre...
(Date:12/1/2009)...VALE, Calif., Dec. 1 GestureTek In... 3.0 - a turnkey, portable, plug and play interact...ibits, entertainment and touring promotions. Gestu...nts in camera-enabled gesture recognition technolo...tainment systems. ,, Guaranteed for quality, th...
(Date:12/1/2009)...inner of the 2009 Inserm Grand Prix., Every year... paying tribute to outstanding,work performed in ...ents, Inserm intends to,demonstrate the diversity...ogical, medical and,health research, and the crea...out and,drive this research each day. The Inserm ...
Breaking Biology News(10 mins):King crab family bigger than ever 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 1Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 2Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 3Abbott Expands XIENCE V 28R 29 USA Trial to Enroll Patients into Landmark Dual Anti Platelet Therapy 28DAPT 29 Trial 13549 4PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 1PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 2PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 3PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 4PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 5PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 6PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 7PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 8Boozing Blunts Ability to Read Faces 54415 1Boozing Blunts Ability to Read Faces 54415 2
...g on new methods to regenerate cartilage and bone ...to instruct them to turn into bone cells. The rese...ciences Research Council (BBSRC), could lead to a ...g populations of Western countries it holds the po...ng joint replacement or similar treatments. , The ...
... Biosciences AG today announced a collaboration to...o generate SNAP-tag fusion proteins based on Gene ...dge,s Red/ET cloning system does not require restr... DNA sequences, such as BACs, (bacterial artificia...NAP-tag is an intelligent self-labeling protein ta...
...ls are faced with everyday obstacles in their phys...sion-making and motor skills to deal with them. Na...x events in mammals and other vertebrates, but in ...bstacle-based system for studying the control and ...ruit fly Drosophila. , The findings are reported ...
Other Biology News:New research could help us deliver genes for new bone formation 2Gene Bridges And Covalys To Develop Restriction-Enzyme-Free SNAP-tag Gene Fusion Kits 2Gap-climbing fruit flies reveal components of goal-driven behaviors 2
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
... can provide custom microplate coating using advan...g equipment that dispenses and washes a variety of...any lot size of the following formats (with a volu...ips, 96 well microplate, 384 well microp...
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Coating Solution Concentrate Kit from KPL
Biology Products: